These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 26764302)

  • 1. [Axonal Regeneration-related Molecules as Biomarkers for Multiple Sclerosis].
    Takahashi K; Tanaka F; Takei K
    Brain Nerve; 2016 Jan; 68(1):82-9. PubMed ID: 26764302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of cerebrospinal fluid levels of lateral olfactory tract usher substance (LOTUS) with disease activity in multiple sclerosis.
    Takahashi K; Kurihara Y; Suzuki Y; Goshima Y; Tanaka F; Takei K
    JAMA Neurol; 2015 Feb; 72(2):176-9. PubMed ID: 25437093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LOTUS suppresses axon growth inhibition by blocking interaction between Nogo receptor-1 and all four types of its ligand.
    Kurihara Y; Iketani M; Ito H; Nishiyama K; Sakakibara Y; Goshima Y; Takei K
    Mol Cell Neurosci; 2014 Jul; 61():211-8. PubMed ID: 25034269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis: does Nogo play a role?
    Lee JY; Petratos S
    Neuroscientist; 2013 Aug; 19(4):394-408. PubMed ID: 23423307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
    Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S
    Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nogo in multiple sclerosis: growing roles of a growth inhibitor.
    Fontoura P; Steinman L
    J Neurol Sci; 2006 Jun; 245(1-2):201-10. PubMed ID: 16682057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble Nogo-A, an inhibitor of axonal regeneration, as a biomarker for multiple sclerosis.
    Jurewicz A; Matysiak M; Raine CS; Selmaj K
    Neurology; 2007 Jan; 68(4):283-7. PubMed ID: 17242333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cartilage acidic protein-1B (LOTUS), an endogenous Nogo receptor antagonist for axon tract formation.
    Sato Y; Iketani M; Kurihara Y; Yamaguchi M; Yamashita N; Nakamura F; Arie Y; Kawasaki T; Hirata T; Abe T; Kiyonari H; Strittmatter SM; Goshima Y; Takei K
    Science; 2011 Aug; 333(6043):769-73. PubMed ID: 21817055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelin regulates immune cell adhesion and motility.
    Pool M; Niino M; Rambaldi I; Robson K; Bar-Or A; Fournier AE
    Exp Neurol; 2009 Jun; 217(2):371-7. PubMed ID: 19328785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The carboxyl-terminal region of Crtac1B/LOTUS acts as a functional domain in endogenous antagonism to Nogo receptor-1.
    Kurihara Y; Arie Y; Iketani M; Ito H; Nishiyama K; Sato Y; Nakamura F; Mizuki N; Goshima Y; Takei K
    Biochem Biophys Res Commun; 2012 Feb; 418(2):390-5. PubMed ID: 22281491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axonal branching in lateral olfactory tract is promoted by Nogo signaling.
    Iketani M; Yokoyama T; Kurihara Y; Strittmatter SM; Goshima Y; Kawahara N; Takei K
    Sci Rep; 2016 Dec; 6():39586. PubMed ID: 28000762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway.
    Linker RA; Lee DH; Ryan S; van Dam AM; Conrad R; Bista P; Zeng W; Hronowsky X; Buko A; Chollate S; Ellrichmann G; Brück W; Dawson K; Goelz S; Wiese S; Scannevin RH; Lukashev M; Gold R
    Brain; 2011 Mar; 134(Pt 3):678-92. PubMed ID: 21354971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nogo receptor antagonist LOTUS exerts suppression on axonal growth-inhibiting receptor PIR-B.
    Kurihara Y; Takai T; Takei K
    J Neurochem; 2020 Nov; 155(3):285-299. PubMed ID: 32201946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid level of Nogo receptor 1 antagonist lateral olfactory tract usher substance (LOTUS) correlates inversely with the extent of neuroinflammation.
    Takahashi K; Takeuchi H; Kurihara Y; Doi H; Kunii M; Tanaka K; Nakamura H; Fukai R; Tomita-Katsumoto A; Tada M; Higashiyama Y; Joki H; Koyano S; Takei K; Tanaka F
    J Neuroinflammation; 2018 Feb; 15(1):46. PubMed ID: 29454354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How does Nogo-A signalling influence mitochondrial function during multiple sclerosis pathogenesis?
    Nheu D; Petratos S
    Neurosci Biobehav Rev; 2024 Aug; 163():105767. PubMed ID: 38885889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Nogo-Nogo receptor pathway limits a spectrum of adult CNS axonal growth.
    Cafferty WB; Strittmatter SM
    J Neurosci; 2006 Nov; 26(47):12242-50. PubMed ID: 17122049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
    Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S
    Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bax-ablation attenuates experimental autoimmune encephalomyelitis in mice.
    Lev N; Barhum Y; Melamed E; Offen D
    Neurosci Lett; 2004 Apr; 359(3):139-42. PubMed ID: 15050683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The promise of stem cell and regenerative therapies for multiple sclerosis.
    Payne N; Siatskas C; Bernard CC
    J Autoimmun; 2008 Nov; 31(3):288-94. PubMed ID: 18504116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of Nogo-A by collagen scaffolds impregnated with bone marrow stromal cell treatment after traumatic brain injury promotes axonal regeneration in rats.
    Mahmood A; Wu H; Qu C; Mahmood S; Xiong Y; Kaplan D; Chopp M
    Brain Res; 2014 Jan; 1542():41-8. PubMed ID: 24177046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.